Treatment Based on High Precision Cardiac Mapping
NCT: NCT07746336 · NOT_YET_RECRUITING
Brief Summary
APOLO-VT aims to evaluate the feasibility, safety, and clinical impact of an integrated multimodal mapping workflow combining non-invasive structural and functional substrate characterization using Volumetric Electrocardiographic Imaging (ECGi) with invasive Electroanatomical Mapping (EAM) to support Ventricular tachycardia (VT) ablation targeting and verification.
Frequently Asked Questions
What is Treatment Based on High Precision Cardiac Mapping?
Treatment Based on High Precision Cardiac Mapping is a clinical trial registered under NCT07746336. Current status: NOT_YET_RECRUITING.
What is the status of NCT07746336?
The current status of NCT07746336 (Treatment Based on High Precision Cardiac Mapping) is: NOT_YET_RECRUITING.
When did Treatment Based on High Precision Cardiac Mapping start?
Treatment Based on High Precision Cardiac Mapping started on 2026-07-15.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.